Effects of angiogenic growth factor combinations on retinal endothelial cells

被引:94
作者
Castellon, R [1 ]
Hamdi, HK [1 ]
Sacerio, I [1 ]
Aoki, AM [1 ]
Kenney, MC [1 ]
Ljubimov, AV [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Cedars Sinai Med Ctr, Ophthalm Res Labs,Burns & Allen Res Inst, Los Angeles, CA 90048 USA
关键词
retinal endothelial cell; diabetic retinopathy; growth factor; matrigel; proliferation; invasion; migration; tube formation; sprouting; synergy; angiogenesis; IGF-I; VEGF; PDGF; FGF-2; PlGF;
D O I
10.1006/exer.2001.1161
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The aim of this paper was to determine if growth factors. known to be upregulated in proliferative diabetic retinopathy, exerted combined effects on retinal endothelial cells. The authors explored the individual and collective actions of insulin-like growth factor I (IGF-I). vascular endothelial growth factor (VEGF), platelet-derived growth factor-BB (PDGF-BB), fibroblast growth factor-2 (FGF-2) and placenta growth factor (PIGF) on several parameters that reflect the angiogenic potential of endothelial cells. The effect of growth factors on cell migration and survival/proliferation was examined using primary cultures of bovine retinal endothelial cells (BREC). The authors also determined the growth factor action on capillary-like tube formation on a reconstituted basement membrane matrix and on the newly described phenomenon of secondary sprouting, in which endothelial cell colonies spontaneously survive, proliferate, migrate and invade the matrix after the original capillary-like tubes have collapsed. Sprouting cells were positive for von Willebrand factor and could aggregate into larger tubes with lumens. Incubation with VEGF+IGF-I or PlGF+FGF-2 enhanced tube stability by 40-50%, more than each growth factor alone or other combinations (5-20%). The concurrent addition of four growth factors did not improve the response seen with growth factor pairs. Surprisingly, PDGF-BB induced tube collapse. IGF-I and FGF-2 mildly enhanced BREC proliferation/survival (5-15 %). However. VEGF+IGF-I or PIGF+FGF-2 increased BREC proliferation/survival by 2 5 % under low serum conditions, whereas combinations of all four growth factors exerted a clearly synergistic effect (2 5 0 % increase). PDGF-1313 or FGF-2 stimulated secondary sprouting and were the only factors capable of exerting this effect alone. Even though VEGF, IGF-I or PIGF were not effective, if administered in pairs, they demonstrated increased responses. PDGF-BB was also able to enhance the effect of FGF-2+IGF-I+VEGF on BREC secondary sprouting, but not of any of them individually. No other growth factor tested was able to significantly improve the action of combinations of three other growth factors. VEGF increased cell migration in a wounded monolayer assay two-fold and PDGF-1313, 2.5 times, but other individual growth factors were ineffective. PlGF+FGF-2 enhanced cell migration more than each factor alone. VEGF+IGF-I+PlGF+FGF-2, however, increased cell migration four-fold. In summary, this study indicates that growth factors, overexpressed in diabetic retinopathy eyes, enhance the angiogenic characteristics of cultured cells (tube formation, proliferation, secondary sprouting and migration). Their effects, however, can be greatly augmented by other growth factors that alone exert little or no action. Therefore, diabetic retinal neovascularization may result from the additive or synergistic action of several growth factors. (C) 2002 Elsevier Science Ltd.
引用
收藏
页码:523 / 535
页数:13
相关论文
共 68 条
[21]   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions [J].
Carmeliet, P ;
Moons, L ;
Luttun, A ;
Vincenti, V ;
Compernolle, V ;
De Mol, M ;
Wu, Y ;
Bon, F ;
Devy, L ;
Beck, H ;
Scholz, D ;
Acker, T ;
DiPalma, T ;
Dewerchin, M ;
Noel, A ;
Stalmans, I ;
Barra, A ;
Blacher, S ;
Vandendriessche, T ;
Ponten, A ;
Eriksson, U ;
Plate, KH ;
Foidart, JM ;
Schaper, W ;
Charnock-Jones, DS ;
Hicklin, DJ ;
Herbert, JM ;
Collen, D ;
Persico, MG .
NATURE MEDICINE, 2001, 7 (05) :575-583
[22]   PURIFICATION AND CHARACTERIZATION OF A NATURALLY-OCCURRING VASCULAR ENDOTHELIAL GROWTH-FACTOR PLACENTA GROWTH-FACTOR HETERODIMER [J].
DISALVO, J ;
BAYNE, ML ;
CONN, G ;
KWOK, PW ;
TRIVEDI, PG ;
SODERMAN, DD ;
PALISI, TM ;
SULLIVAN, KA ;
THOMAS, KA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) :7717-7723
[23]   Kinetics of placenta growth factor/vascular endothelial growth factor synergy in endothelial hydraulic conductivity and proliferation [J].
Dull, RO ;
Yuan, J ;
Chang, YS ;
Tarbell, J ;
Jain, RK ;
Munn, LL .
MICROVASCULAR RESEARCH, 2001, 61 (02) :203-210
[24]   Interactions between growth hormone, insulin-like growth factor I, and basic fibroblast growth factor in melanocyte growth [J].
Edmondson, SR ;
Russo, VC ;
McFarlane, AC ;
Wraight, CJ ;
Werther, GA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (05) :1638-1644
[25]  
Favard C, 1996, DIABETES METAB, V22, P268
[26]   Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy [J].
Freyberger, H ;
Bröcker, M ;
Yakut, H ;
Hammer, J ;
Effert, R ;
Schifferdecker, E ;
Schatz, N ;
Derwahl, M .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2000, 108 (02) :106-109
[27]   INSULIN-LIKE GROWTH-FACTORS ACT SYNERGISTICALLY WITH BASIC FIBROBLAST GROWTH-FACTOR AND NERVE GROWTH-FACTOR TO PROMOTE CHROMAFFIN CELL-PROLIFERATION [J].
FRODIN, M ;
GAMMELTOFT, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (05) :1771-1775
[28]  
GOTO F, 1993, LAB INVEST, V69, P508
[29]   INSULIN-LIKE GROWTH-FACTORS IN VITREOUS - STUDIES IN CONTROL AND DIABETIC SUBJECTS WITH NEOVASCULARIZATION [J].
GRANT, M ;
RUSSELL, B ;
FITZGERALD, C ;
MERIMEE, TJ .
DIABETES, 1986, 35 (04) :416-420
[30]  
GRANT MB, 1991, INVEST OPHTH VIS SCI, V32, P53